Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 4
2019 5
2020 3
2021 2
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Reply to Standaert, B. Comment on "Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium".
Postma MJ, Cheng CY, Buyukkaramikli NC, Hernandez Pastor L, Vandersmissen I, Van Effelterre T, Openshaw P, Simoens S. Postma MJ, et al. Among authors: buyukkaramikli nc. Vaccines (Basel). 2023 Nov 1;11(11):1673. doi: 10.3390/vaccines11111673. Vaccines (Basel). 2023. PMID: 38006005 Free PMC article.
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple Myeloma.
Palmer S, Lin Y, Martin TG, Jagannath S, Jakubowiak A, Usmani SZ, Buyukkaramikli N, Phelps H, Slowik R, Pan F, Valluri S, Pacaud L, Jackson G. Palmer S, et al. Among authors: buyukkaramikli n. Oncol Ther. 2023 Sep;11(3):313-326. doi: 10.1007/s40487-023-00230-x. Epub 2023 Jun 4. Oncol Ther. 2023. PMID: 37270762 Free PMC article.
Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium.
Postma MJ, Cheng CY, Buyukkaramikli NC, Hernandez Pastor L, Vandersmissen I, Van Effelterre T, Openshaw P, Simoens S. Postma MJ, et al. Among authors: buyukkaramikli nc. Vaccines (Basel). 2023 May 16;11(5):990. doi: 10.3390/vaccines11050990. Vaccines (Basel). 2023. PMID: 37243094 Free PMC article.
Economic Burden of COVID-19: A Systematic Review.
Richards F, Kodjamanova P, Chen X, Li N, Atanasov P, Bennetts L, Patterson BJ, Yektashenas B, Mesa-Frias M, Tronczynski K, Buyukkaramikli N, El Khoury AC. Richards F, et al. Among authors: buyukkaramikli n. Clinicoecon Outcomes Res. 2022 Apr 28;14:293-307. doi: 10.2147/CEOR.S338225. eCollection 2022. Clinicoecon Outcomes Res. 2022. PMID: 35509962 Free PMC article. Review.
10 Years of End-of-Life Criteria in the United Kingdom.
Bovenberg J, Penton H, Buyukkaramikli N. Bovenberg J, et al. Among authors: buyukkaramikli n. Value Health. 2021 May;24(5):691-698. doi: 10.1016/j.jval.2020.11.015. Epub 2021 Mar 20. Value Health. 2021. PMID: 33933238 Free article.
Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.
Armstrong N, Büyükkaramikli N, Penton H, Riemsma R, Wetzelaer P, Huertas Carrera V, Swift S, Drachen T, Raatz H, Ryder S, Shah D, Buksnys T, Worthy G, Duffy S, Al M, Kleijnen J. Armstrong N, et al. Among authors: buyukkaramikli n. Health Technol Assess. 2020 Oct;24(51):1-220. doi: 10.3310/hta24510. Health Technol Assess. 2020. PMID: 33108266 Free PMC article.
21 results